Cassava Sciences Inc. buy tbackenh
Start price
26.09.16
/
50%
€6.69
Target price
26.09.16
€17.43
Performance (%)
22.64%
End price
26.09.16
€8.21
Summary
This prediction ended on 26.09.16 with a price of €8.21. The BUY prediction by tbackenh finished with a performance of 22.64%. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cassava Sciences Inc. | -4.859% | -4.859% | -35.142% | -94.325% |
| iShares Core DAX® | -1.875% | 2.861% | 18.863% | 63.672% |
| iShares Nasdaq 100 | -2.177% | 0.048% | 3.956% | 109.562% |
| iShares Nikkei 225® | -0.867% | 6.987% | 21.062% | 54.912% |
| iShares S&P 500 | -1.253% | 1.248% | 2.246% | 69.801% |
Comments by tbackenh for this prediction
In the thread Cassava Sciences Inc. diskutieren
Pain Therapeutics
Die Zulassung des Schmerzmittels wurde verweigert, 65% Kursverlust waren die Folge. Erscheint mir etwas übertrieben, setze auf Gegenreaktion.
(Vom Mitglied beendet)


